Bio-Rad Laboratories, Inc.
BIO
$245.01
-$6.14-2.45%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.84B | -778.67M | -1.33B | -322.35M | -637.30M |
| Total Depreciation and Amortization | 151.60M | 149.60M | 148.00M | 147.40M | 145.90M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.77B | 1.45B | 2.16B | 860.02M | 1.30B |
| Change in Net Operating Assets | -620.80M | -413.00M | -636.20M | -338.50M | -432.80M |
| Cash from Operations | 455.20M | 412.00M | 346.15M | 346.57M | 374.90M |
| Capital Expenditure | -165.60M | -164.95M | -168.79M | -161.15M | -156.70M |
| Sale of Property, Plant, and Equipment | 100.00K | 245.00K | 253.00K | 226.00K | 200.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | 2.50M | 2.50M | 2.50M | 2.50M |
| Other Investing Activities | 5.30M | 104.74M | 154.71M | 206.01M | 174.20M |
| Cash from Investing | -160.20M | -57.47M | -11.33M | 47.58M | 20.20M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -400.00K | -510.00K | -505.00K | -503.00K | -500.00K |
| Issuance of Common Stock | 19.20M | 19.62M | 19.17M | 19.58M | 18.50M |
| Repurchase of Common Stock | -207.00M | -411.62M | -341.78M | -448.35M | -443.60M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -30.60M | -617.00K | -617.00K | -617.00K | -- |
| Cash from Financing | -218.80M | -393.13M | -323.74M | -429.89M | -425.60M |
| Foreign Exchange rate Adjustments | 9.20M | -7.51M | 6.22M | 5.06M | 400.00K |
| Miscellaneous Cash Flow Adjustments | 0.00 | 52.00K | 0.00 | 0.00 | 0.00 |
| Net Change in Cash | 85.40M | -46.05M | 17.31M | -30.68M | -30.10M |
